Abstract

Alpha B‐crystallin (CRYAB) is overexpressed in a variety of cancers. However, little is known about its specific function and regulatory mechanism in gastric cancer. Here, we first explore the role of CRYAB in gastric cancer progression and metastasis. The expression of CRYAB was determined by western blot and immunohistochemistry in gastric cancer tissues. Besides, methods including stably transfected against CRYAB into gastric cancer cells, western blot, migration and invasion assays in vitro and metastasis assay in vivo were also conducted. The expression of CRYAB is up‐regulated in gastric cancer tissues compared with matched normal tissues. High expression level of CRYAB is closely correlated with cancer metastasis and shorter survival time in patients with gastric cancer. Additionally, CRYAB silencing significantly suppresses epithelial‐mesenchymal transition (EMT), migration and invasion of gastric cancer cells in vitro and in vivo, whereas CRYAB overexpression dramatically reverses these events. Mechanically, CRYAB facilitates gastric cancer cells invasion and metastasis via nuclear factor‐κ‐gene binding (NF‐κB)‐regulated EMT. These findings suggest that CRYAB expression predicts a poor prognosis in patients with gastric cancer. Besides, CRYAB contributes to gastric cancer cells migration and invasion via EMT, mediated by the NF‐κB signalling pathway, thus possibly providing a novel therapeutic target for gastric cancer.

Highlights

  • Gastric cancer is the fifth most common malignancy[1] and is the third leading cause of cancer-related mortality worldwide.[2]

  • As numerous genetic changes are in relation to cancer cell invasion and metastasis,[14,19,20,21,22] great efforts have been made in the identification of novel key regulators and the potential mechanisms involved in this process over the years

  • Recent studies have revealed that CRYAB is aberrantly overexpressed in various types of cancer, and its expression could promote cell invasion and metastasis.[8,9,10]

Read more

Summary

| INTRODUCTION

Gastric cancer is the fifth most common malignancy[1] and is the third leading cause of cancer-related mortality worldwide.[2]. Identification of novel metastases-related biomarkers and investigation of the underlying mechanisms driving gastric cancer metastasis may provide potential targets useful for improving outcomes. This study aimed to explore the functional role of CRYAB in the invasion and metastasis of gastric cancer, as well as the molecular mechanisms responsible for CRYAB function

| METHODS
| RESULTS
Findings
| DISCUSSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.